148 related articles for article (PubMed ID: 25723461)
1. Role of 2-methoxyestradiol, an Endogenous Estrogen Metabolite, in Health and Disease.
Parada-Bustamante A; Valencia C; Reuquen P; Diaz P; Rincion-Rodriguez R; Orihuela PA
Mini Rev Med Chem; 2015; 15(5):427-38. PubMed ID: 25723461
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of 2-methoxyestradiol: new developments.
Mooberry SL
Drug Resist Updat; 2003 Dec; 6(6):355-61. PubMed ID: 14744499
[TBL] [Abstract][Full Text] [Related]
3. Synthetic 2-methoxyestradiol derivatives: structure-activity relationships.
Peyrat JF; Brion JD; Alami M
Curr Med Chem; 2012; 19(24):4142-56. PubMed ID: 22709003
[TBL] [Abstract][Full Text] [Related]
4. Estradiol 17β and its metabolites stimulate cell proliferation and antagonize ascorbic acid-suppressed cell proliferation in human ovarian cancer cells.
Li HH; Zhao YJ; Li Y; Dai CF; Jobe SO; Yang XS; Li XF; Patankar MS; Magness RR; Zheng J
Reprod Sci; 2014 Jan; 21(1):102-11. PubMed ID: 23757313
[TBL] [Abstract][Full Text] [Related]
5. New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent.
Mooberry SL
Curr Opin Oncol; 2003 Nov; 15(6):425-30. PubMed ID: 14624224
[TBL] [Abstract][Full Text] [Related]
6. The Bone Sparing Effects of 2-Methoxyestradiol Are Mediated via Estrogen Receptor-α in Male Mice.
Eriksson AL; Wilhelmson AS; Fagman JB; Ryberg H; Koskela A; Tuukkanen J; Tivesten Å; Ohlsson C
Endocrinology; 2016 Nov; 157(11):4200-4205. PubMed ID: 27631553
[TBL] [Abstract][Full Text] [Related]
7. 2-methoxyestradiol binding of GPR30 down-regulates angiotensin AT(1) receptor.
Koganti S; Snyder R; Gumaste U; Karamyan VT; Thekkumkara T
Eur J Pharmacol; 2014 Jan; 723():131-40. PubMed ID: 24262995
[TBL] [Abstract][Full Text] [Related]
8. Structure activity analysis of 2-methoxyestradiol analogues reveals targeting of microtubules as the major mechanism of antiproliferative and proapoptotic activity.
Chua YS; Chua YL; Hagen T
Mol Cancer Ther; 2010 Jan; 9(1):224-35. PubMed ID: 20053769
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation by the estrogen metabolite 2-methoxyestradiol.
Stubelius A; Erlandsson MC; Islander U; Carlsten H
Clin Immunol; 2014 Jul; 153(1):40-8. PubMed ID: 24691416
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in chemistry and pharmacology of 2-methoxyestradiol: An anticancer investigational drug.
Kumar BS; Raghuvanshi DS; Hasanain M; Alam S; Sarkar J; Mitra K; Khan F; Negi AS
Steroids; 2016 Jun; 110():9-34. PubMed ID: 27020471
[TBL] [Abstract][Full Text] [Related]
11. 2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells.
Chauhan D; Catley L; Hideshima T; Li G; Leblanc R; Gupta D; Sattler M; Richardson P; Schlossman RL; Podar K; Weller E; Munshi N; Anderson KC
Blood; 2002 Sep; 100(6):2187-94. PubMed ID: 12200384
[TBL] [Abstract][Full Text] [Related]
12. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis.
Ashburn SP; Han X; Liehr JG
Mol Pharmacol; 1993 Apr; 43(4):534-41. PubMed ID: 8386306
[TBL] [Abstract][Full Text] [Related]
13. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol.
Dawling S; Hachey DL; Roodi N; Parl FF
Chem Res Toxicol; 2004 Sep; 17(9):1258-64. PubMed ID: 15377160
[TBL] [Abstract][Full Text] [Related]
14. Comparative properties of the catechol estrogens, I: methylation by catechol-O-methyltransferase and binding to cytosol estrogen receptors.
Merriam GR; MacLusky NJ; Picard MK; Naftolin F
Steroids; 1980 Jul; 36(1):1-11. PubMed ID: 7426122
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mitochondrial respiration by the anticancer agent 2-methoxyestradiol.
Hagen T; D'Amico G; Quintero M; Palacios-Callender M; Hollis V; Lam F; Moncada S
Biochem Biophys Res Commun; 2004 Sep; 322(3):923-9. PubMed ID: 15336552
[TBL] [Abstract][Full Text] [Related]
16. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?
Zhu BT; Conney AH
Cancer Res; 1998 Jun; 58(11):2269-77. PubMed ID: 9622057
[TBL] [Abstract][Full Text] [Related]
17. 2-methoxyestradiol inhibits the anaphase-promoting complex and protein translation in human breast cancer cells.
Bhati R; Gökmen-Polar Y; Sledge GW; Fan C; Nakshatri H; Ketelsen D; Borchers CH; Dial MJ; Patterson C; Klauber-DeMore N
Cancer Res; 2007 Jan; 67(2):702-8. PubMed ID: 17234781
[TBL] [Abstract][Full Text] [Related]
18. Catechol-o-methyltransferase expression and 2-methoxyestradiol affect microtubule dynamics and modify steroid receptor signaling in leiomyoma cells.
Salama SA; Kamel MW; Botting S; Salih SM; Borahay MA; Hamed AA; Kilic GS; Saeed M; Williams MY; Diaz-Arrastia CR
PLoS One; 2009 Oct; 4(10):e7356. PubMed ID: 19809499
[TBL] [Abstract][Full Text] [Related]
19. 2-hydroxyoestradiol and 2-methoxyoestradiol, two endogenous oestradiol metabolites, induce DNA fragmentation in Sertoli cells.
Valencia C; Molina C; Florez M; Buñay J; Moreno RD; Orihuela PA; Castro A; Parada-Bustamante A
Andrologia; 2016 Dec; 48(10):1294-1306. PubMed ID: 27071496
[TBL] [Abstract][Full Text] [Related]
20. 2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism.
Schaufelberger SA; Rosselli M; Barchiesi F; Gillespie DG; Jackson EK; Dubey RK
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E313-22. PubMed ID: 26732685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
